Site içinde arama yapın

Shubham Choudhry bir ses eklendi Other
2026-04-28 14:09:48 -

Monoclonal Antibody Therapeutics (mABs) Market Growth, Size, and Future Outlook (2025–2031)
The monoclonal antibody therapeutics (mABs) market has emerged as a cornerstone of modern biopharmaceutical innovation, driven by the increasing prevalence of chronic diseases, rising demand for targeted therapies, and advancements in biotechnology. Monoclonal antibodies are engineered proteins designed to bind to specific antigens, offering high precision in treating diseases such as cancer,...

0 Yorumlar 0 hisse senetleri 426 Views 0 önizleme

Please log in to like, share and comment!
Rahul Rangwa bir ses eklendi Other
2025-09-03 04:27:33 -

Monoclonal Antibody Therapeutics Market Driven by Breakthroughs in Targeted Treatments
"Regional Overview of Executive Summary Monoclonal Antibody Therapeutics Market by Size and Share CAGR Value The global monoclonal antibody therapeutics market / mABs therapeutics market size was valued at USD 263.22 billion in 2024 and is expected to reach USD 719.81 billion by 2032, at a CAGR of 13.40% during the forecast period A study about the Monoclonal...

0 Yorumlar 0 hisse senetleri 918 Views 0 önizleme

Please log in to like, share and comment!
Subhayan Mayra bir ses eklendi Other
2026-06-12 10:19:46 -

United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...

0 Yorumlar 0 hisse senetleri 500 Views 0 önizleme

Please log in to like, share and comment!